Open Access
Adverse drug reactions to antiretroviral medication
Bernardino Roca1
Hospital General of Castellon, University of Valencia, Spain
DOI: 10.2741/3340 Volume 14 Issue 5, pp.1785-1792
Published: 01 January 2009
(This article belongs to the Special Issue New insights in diagnosis and treatment of allergic diseases)

Antiretroviral therapy has greatly improved prognosis of HIV infection, with a dramatic reduction of morbidity and mortality worldwide. Nevertheless, the condition is still a common cause of death in many underdeveloped countries, where effective treatment is not always unavailable. More than 20 drugs active against HIV are commercially available, which belong to one of four groups: nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, and fusion/entry inhibitors. In the near future new drugs are expected, including those of a novel group, the integrase inhibitors. To avoid viral resistance, combinations of the drugs must always be used in clinical practice. Adverse reactions are common with antiretrovirals, and they are an important cause of medication non-adherence and suboptimal control of HIV infection. In this article we review the most relevant of those toxicities.

Share and Cite
Bernardino Roca. Adverse drug reactions to antiretroviral medication. Frontiers in Bioscience-Landmark. 2009. 14(5); 1785-1792.